Overview
- 8 FDA inspections are on record.
- 7 inspections produced a Form 483.
- The most recent recorded inspection date is 2026-05-13.
At a glance
Inspections
8
Form 483s
7
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 5 May 2026 – 13 May 2026 | Human Drugs | 483 | View 483 → |
| 5 Jun 2023 – 9 Jun 2023 | Human Drugs | 483 | View 483 → |
| 25 Jan 2019 – 7 Feb 2019 | Human Drugs | 483 | On file |
| 18 Dec 2017 – 28 Dec 2017 | Human Drugs | 483 | View 483 → |
| 21 Mar 2017 – 4 Apr 2017 | Human Drugs | 483 | On file |
| 1 Nov 2016 – 8 Nov 2016 | Human Drugs | 483 | On file |
| 28 Sep 2015 – 30 Oct 2015 | Human Drugs | 483 | View 483 → |
| 27 Apr 2015 – 28 Apr 2015 | Human Drugs | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
13 May 2026
21 CFR 211.113(a)
Procedures for non-sterile drug products
Cited by Suchan Kim, Alisha B Patel
13 May 2026
21 CFR 211.194(c)
Testing and standardization of standards et. al.
Cited by Suchan Kim, Alisha B Patel
13 May 2026
21 CFR 211.80(b)
Handling and Storage to Prevent Contamination
Cited by Suchan Kim, Alisha B Patel
Investigators
FDA investigators tied to this site in the record.
Nancy M Espinal2 insp.
Paul L Bellamy2 insp.
Suchan Kim1 insp.
Alisha B Patel1 insp.
Syeda N Mahazabin1 insp.
Yvesna C Blaise1 insp.
Russell J Glapion1 insp.
Frederick Razzaghi1 insp.
Maria Estrella1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.165(e) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.194(a)(2) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.68(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.84(d)(2) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.103 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.110(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.111 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.113(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.122(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.142(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.165(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.170(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.194(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.63 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.67(b)(3) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.80(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.84(b) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind InvaTech Pharma Solutions, LLC's 7 Form 483s
Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat